ArticleNeuromodulation : journal of the International Neuromodulation Society2026
Magnetic Resonance Imaging Monitoring of the Safety of Repeated Low-Intensity Focused Ultrasound Exposure at Three Brain Locations.
Article in Neuromodulation : journal of the International Neuromodulation Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Low-Intensity Focused Ultrasound Neuromodulation in Psychiatric Disorders: Mechanisms, Models, and Missing Links.Biological psychiatry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesTranscranial focused ultrasound stimulation (FUS) integrated with magnetic resonance (MR) acoustic radiation force imaging (ARFI) enables real-time localization of the FUS beam, a highly desirable feature for neuromodulation. Because MR-ARFI requires higher acoustic pressure, it is essential to establish the safety of repeated sonication during both ARFI and FUS procedures. MATERIALS AND
methodsSix macaque monkeys underwent repeated neuromodulation studies targeting three brain regions: the thalamic ventroposterior lateral (VPL) nucleus, anterior cingulate cortex (ACC), and periaqueductal gray (PAG). Susceptibility-weighted imaging (SWI) and fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI) sequences, sensitive to microbleeds, edema, and lesions, were acquired during each session. MRI signals from target regions were quantified and compared with control regions of interest with similar tissue properties. Signal variability within two SDs was considered negative, indicating no detectable damage. Data acquisition intervals ranged from two weeks to >one year. Histologic analysis with Hematoxylin and Eosin and glial fibrillary acidic protein stains was performed on one PAG target.
resultsNo evidence of tissue damage was detected at any of the three targeted brain regions on SWI or FLAIR imaging. Signal variability for all targets remained within two SDs. Histologic evaluation revealed evenly distributed staining with no signs of tissue damage or neuroinflammation. These findings apply to both neuromodulation pulses delivered within current guidelines and MR-ARFI pulses exceeding current guideline limits.
conclusionsRepeated sonication of cortical, deep brain, and brainstem regions caused no detectable tissue damage, supporting a preliminary safety profile for clinical applications using similar MR-guided FUS protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.